Search research articles
Contact Us
Filters
Showing results (51-60 of 799) with videos related to
Page
of 80
Sort By:
The American Journal of Psychiatry
|
February 4, 2003
Depression, IV: STAR*D treatment trial for depression
A John Rush, Madhukar Trivedi, Maurizio Fava
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 12, 2010
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder
George I Papakostas, Dana Charles, Maurizio Fava
The Psychiatric Clinics of North America
|
March 17, 2007
A critical overview of the pharmacologic management of treatment-resistant depression
Andrew A Nierenberg, Judith Katz, Maurizio Fava
Translational Psychiatry
|
April 29, 2023
Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placebo
Roberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Journal of Clinical Pharmacology
|
January 27, 2018
Is It Time for Going Beyond the P-Value Paradigm With the Estimation of the Probability of Clinical Benefit as a Criterion for Assessing the Outcomes of a Clinical Trial? A Case Study in Patients With Major Depressive Disorder
Roberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Molecular Psychiatry
|
June 25, 2026
Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions
Clotilde Guidetti, Maurizio Fava, George I Papakostas
Journal of Biopharmaceutical Statistics
|
February 23, 2019
A commentary on: statistical inference problems in sequential parallel comparison designs
David Alan Schoenfeld, Gheorghe Doros, Maurizio Fava
The Journal of Clinical Psychiatry
|
May 1, 2009
Closing the efficacy-effectiveness gap: translating both the what and the how from randomized controlled trials to clinical practice
Anthony P Weiss, Jenny Guidi, Maurizio Fava
Current Psychiatry Reports
|
May 15, 2004
Impact of medical comorbid disease on antidepressant treatment of major depressive disorder
Dan V Iosifescu, Bettina Bankier, Maurizio Fava
Psychiatry Research
|
August 6, 2023
A new method for analyzing clinical trials in depression based on individual propensity to respond to placebo estimated using artificial intelligence
Roberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Page
of 80
Search research articles
Search
Showing results (51-60 of 799) with videos related to
Sort By:
Page
of 80
The American Journal of Psychiatry
|
February 4, 2003
Depression, IV: STAR*D treatment trial for depression
A John Rush, Madhukar Trivedi, Maurizio Fava
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 12, 2010
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder
George I Papakostas, Dana Charles, Maurizio Fava
The Psychiatric Clinics of North America
|
March 17, 2007
A critical overview of the pharmacologic management of treatment-resistant depression
Andrew A Nierenberg, Judith Katz, Maurizio Fava
Translational Psychiatry
|
April 29, 2023
Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placebo
Roberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Journal of Clinical Pharmacology
|
January 27, 2018
Is It Time for Going Beyond the P-Value Paradigm With the Estimation of the Probability of Clinical Benefit as a Criterion for Assessing the Outcomes of a Clinical Trial? A Case Study in Patients With Major Depressive Disorder
Roberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Molecular Psychiatry
|
June 25, 2026
Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions
Clotilde Guidetti, Maurizio Fava, George I Papakostas
Journal of Biopharmaceutical Statistics
|
February 23, 2019
A commentary on: statistical inference problems in sequential parallel comparison designs
David Alan Schoenfeld, Gheorghe Doros, Maurizio Fava
The Journal of Clinical Psychiatry
|
May 1, 2009
Closing the efficacy-effectiveness gap: translating both the what and the how from randomized controlled trials to clinical practice
Anthony P Weiss, Jenny Guidi, Maurizio Fava
Current Psychiatry Reports
|
May 15, 2004
Impact of medical comorbid disease on antidepressant treatment of major depressive disorder
Dan V Iosifescu, Bettina Bankier, Maurizio Fava
Psychiatry Research
|
August 6, 2023
A new method for analyzing clinical trials in depression based on individual propensity to respond to placebo estimated using artificial intelligence
Roberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Page
of 80